PMID- 7872477
OWN - NLM
STAT- MEDLINE
DCOM- 19950329
LR  - 20190914
IS  - 0196-0709 (Print)
IS  - 0196-0709 (Linking)
VI  - 15
IP  - 6
DP  - 1994 Nov-Dec
TI  - Imaging modalities in the follow-up of non-iodine avid thyroid carcinoma.
PG  - 417-22
AB  - INTRODUCTION: The treatment of primary thyroid cancer requires protracted 
      follow-up because of to the possibility of the development of recurrent 
      metastases many years after the initial diagnosis. Often such follow-up involves 
      imaging at regular intervals with diagnostic I-131 studies. However, not all 
      thyroid cancer concentrates I-131. The purpose of this article is to review the 
      efficacy of alternative diagnostic imaging modalities for follow-up of thyroid 
      carcinomas that do not concentrate radioiodine. MATERIALS AND METHODS: These 
      procedures include the use of nuclear medicine imaging with thallium-201 
      (TI-201), Tc-99m-sestamibi, Tc-99m pentavalent dimercaptosuccinic acid (DMSA), 
      radiolabeled anti-carcinoembryonic antigen antibodies, and radioiodinated-131 
      meta-iodobenzyl guanidine, as well as computerized x-ray tomography, magnetic 
      resonance imaging (MRI), and ultrasound (US). RESULTS AND CONCLUSION: 
      Thallium-201, MRI, and pentavalent DMSA provide adequate sensitivity for 
      follow-up of selected patients with suspected recurrent noniodine concentrating 
      thyroid carcinoma.
FAU - Mallin, W H
AU  - Mallin WH
AD  - Department of Radiology, Eugene L. Saenger Radioisotope Laboratory, University of 
      Cincinnati Medical Center, OH 45267-0577.
FAU - Elgazzar, A H
AU  - Elgazzar AH
FAU - Maxon, H R 3rd
AU  - Maxon HR 3rd
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Am J Otolaryngol
JT  - American journal of otolaryngology
JID - 8000029
RN  - 0 (Iodine Radioisotopes)
RN  - 0 (Iodobenzenes)
RN  - 0 (Organotechnetium Compounds)
RN  - 0 (Thallium Radioisotopes)
RN  - 35MRW7B4AD (3-Iodobenzylguanidine)
RN  - 37CB58V15B (thallium chloride)
RN  - 494JNQ8L28 (Technetium Tc 99m Dimercaptosuccinic Acid)
RN  - 971Z4W1S09 (Technetium Tc 99m Sestamibi)
RN  - AD84R52XLF (Thallium)
RN  - DX1U2629QE (Succimer)
SB  - IM
MH  - 3-Iodobenzylguanidine
MH  - *Diagnostic Imaging
MH  - Follow-Up Studies
MH  - Humans
MH  - Iodine Radioisotopes
MH  - Iodobenzenes
MH  - Organotechnetium Compounds
MH  - Radioimmunodetection
MH  - Succimer
MH  - Technetium Tc 99m Dimercaptosuccinic Acid
MH  - Technetium Tc 99m Sestamibi
MH  - Thallium
MH  - Thallium Radioisotopes
MH  - Thyroid Neoplasms/*diagnosis/epidemiology
RF  - 40
EDAT- 1994/11/01 00:00
MHDA- 2001/03/28 10:01
CRDT- 1994/11/01 00:00
PHST- 1994/11/01 00:00 [pubmed]
PHST- 2001/03/28 10:01 [medline]
PHST- 1994/11/01 00:00 [entrez]
AID - 0196-0709(94)90082-5 [pii]
AID - 10.1016/0196-0709(94)90082-5 [doi]
PST - ppublish
SO  - Am J Otolaryngol. 1994 Nov-Dec;15(6):417-22. doi: 10.1016/0196-0709(94)90082-5.